- Open Access
Aluminosis – Detection of an almost forgotten disease with HRCT
Journal of Occupational Medicine and Toxicologyvolume 1, Article number: 4 (2006)
The aim of this study was to investigate whether it is possible to detect high-resolution computed tomography (HRCT) findings in aluminium powder workers, which are consistent with early stages of aluminosis.
62 male workers from 8 departments of two plants producing aluminium (Al) powder were investigated using a standardized questionnaire, physical examination, lung function analysis, biological monitoring of Al in plasma and urine, chest X-ray, HRCT and immunological tests.
Chronic bronchitis was observed in 15 (24.2%) of the workers, and four workers (6.5%) reported shortness of breath during exercise. HRCT findings in 15 workers (24.2%) were characterized by ill-defined centrilobular nodular opacities. Workers with ill-defined centrilobular nodular opacities had a lower vital capacity than workers who had no such HRCT-findings (90.9 % pred. vs. 101.8 % pred., p = 0.01). Biological monitoring in plasma and urine revealed higher internal exposure to Al in affected workers (33.5 μg/l plasma to 15.4 μg/l plasma, p = 0.01) and (340.5 μg/g creat. to 135.1 μg/g creat., p = 0.007). Years of exposure and concentration of aluminum in urine and plasma appear to be the best predictors for HRCT findings. Age and decreased vital capacity show borderline significance.
We conclude that aluminosis is still relevant in occupational medicine. With HRCT it is possible to detect early stages of aluminosis and biological monitoring can be used to define workers at high risk.
The influence of the toxicity of aluminium and its compounds on humans has been the cause of much controversy for many years. Since the 1930's an 40's it has been known that high-level and long term occupational exposure to metallic aluminium powder and aluminium oxide can cause lung disease. At that time emphasis was placed on the short and long term effect of toxicity on the respiratory tract [4–7]. Recently the main discussion has been on the neurotoxicity and in particular on the controversial relationship between Alzheimer's disease and occupational or environmental exposure to aluminium [1–3]. It was assumed that under today's working conditions lung fibrosis induced by aluminium dust could not occur anymore [6, 7]. However, several severe cases of aluminium-induced lung fibrosis have occurred in the last 15 years in Germany [8–10] (Fig. 1).
Histological examination of lung tissue samples showed severe subpleural and interstitial fibrosis with scar emphysema and spotted granulomateous pneumonitis with giant cells. Energy dispersed X-ray analysis of this case showed high concentrations of aluminium in the interstitial zones . The pathogenesis of lung diseases induced by aluminium dust is still unclear. It has been much discussed whether only non-greased aluminium powder (pyro powder) or also greased aluminium powder can cause lung changes. The question is whether diverse additives, in particular stearic acids, are a pathogenetic factor in the development of lung fibrosis [4, 5, 8]. At first, diseases were detected in employees exposed only to high concentrations of stamped, non-greased aluminium flake powder. In the production process of aluminium powder, different amounts of stearic acid are added depending on its later use. Non-greased or barely-greased aluminium powder with a stearin content of less than 0.1 % (acetone extract) is used for sintered metals in powder metallurgy and in the production of fireworks, rockets and explosives in pyrotechnics. In other production fields (e.g. in the production of porous concrete and pigments for metallic paints) mainly greased aluminium powders are used in paste form or as granules with a lower exposure to dust. The threshold values for disease prevention, currently valid in Germany, are a maximum concentration at the workplace (MAK value) of 4 mg/m3 as inhalable dust, 1.5 mg/m3 as respirable dust and a biological tolerance value at the workplace (BAT value) of 200 μg/l in urine .
Aluminium lung is characterized as diffuse interstitial fibrosis which is mainly located in the upper and middle lobes of the lung. In advanced stages it is characterized by subpleural bullous emphysema with an increased risk of spontaneous pneumothorax . The prognosis for severe forms of lung fibrosis is poor because the disease can continue to progress after the end of exposure. Therefore early detection of aluminium induced fibrotic changes is invaluable to the timely introduction of preventative measures. Early stage lung changes, induced by aluminium dust, could not be diagnosed to date using conventional X-rays in several cross-sectional studies in the aluminium powder industry  or during general occupational medical surveillance.
The aim of this study is to check whether sensitive tools for the detection of interstitial lung diseases, such as high resolution computed tomography (HR-CT), allow for the early detection of aluminium induced lung disease.
Study group and Methods
In a cross-sectional study, male workers were examined in two plants producing aluminium powder in Germany. The examination was offered to all workers from 8 departments, who had a high exposure to aluminium powder. In plant A, 34 of 76 high-exposed workers (44.7%) took part in the study. In plant B, 28 of 44 high-exposed workers (63.6%) from the production units gave their informed consent. None of the workers refused due to medical reasons to take part in the study. The age of the workers ranged between 22 and 64 years with a median of 41 years (mean 41.4, SD 9.9 yrs). The smoking history of the workers (20 non-smokers, 32 current smokers, 10 former smokers) was quantified by the cumulative cigarette consumption expressed in pack-years (PY).
The study design included a standardized history with special attention to occupational history including former exposures to fibrotic agents, a physical examination of the cardiopulmonary system, biological monitoring of aluminium in urine and in plasma, lung function analysis and conventional X-rays (first 28 consecutively examined workers only) and high resolution computed tomography with standardized technical parameters . Sufficient data on ambient monitoring results from the two plants were not available retrospectively.
Aluminium concentrations in plasma and urine were determined by graphite furnace atomic absorption spectrometry (GF-AAS) under the conditions of internal and external quality assurance [13, 14]. Bodyplethysmography and spirometry were performed with a Jaeger-Masterlab (Jaeger-Toennies GmbH, Germany) according to ATS criteria . It included measurements of the vital capacity (VC), forced expiratory volume (FEV1), total resistance (Rtot), and total lung capacity (TLC). Lung function measurements relative to the corresponding reference values proposed by the European Community for Coal and Steel  were used in the analysis. Evaluation of the conventional X-rays was performed using the ILO-classification for pneumoconiosis , by an experienced blinded (no knowledge of the quantitative exposure or clinical data) radiologist. After the first 28 consecutive chest X-ray examinations, this method was discontinued due to the lack of aluminium-related findings in the chest X-rays. The HRCT was performed during breath-holding at full inspiration with a Somatom plus4 scanner from Siemens, Erlangen. Slice thickness was 1 mm with a slice interval of 10 mm. The evaluation of the CT scans was performed with a semi-quantitative score system for CT . Similar to the ILO-Classification for pneumoconioses small rounded opacities, irregular and linear opacities, emphysema, honeycombing and ground glass pattern as well as pleural plaques and diffuse pleura thickening were quantified as profusion grade (parenchyma) and thickness and extent (pleura).
In the case of suspected aluminium-related findings, further diagnostic tests were performed to exclude other interstitial lung diseases. These tests included ergometry, diffusion capacity (DLCO single breath method), blood gas analysis, and immunological parameters (Table 5). These parameters were C-reactive protein, anti-ribonuclease, rheumatoid factor, Rose-Waaler test, antinucleic antibodies (ANA) fluorescence test, ribonucleoprotein /Sm antibodies, U1-ribonucleoprotein antibodies, sm antibodies, Sjoegren-syndrome-A-antibodies (Ro and La), sclerodermia-70-antibodies, CENP-B-antibodies, anti-Jo-antibodies, antimitochondrial antibodies and neutrophile cytoplasmatic antibodies (AK/C and AK/P). Specific IgG antibodies were analyzed for Penicillium notatum, Cladosporium herbarum and Aspergillus fumigatus. Specific IgE antibodies were analyzed for grasses, tree pollen (beech, alder, birch, hazel), flakes of cat skin, mold (Penicillium notatum, Cladosporium herbarum, Aspergillus fumigatus), household dust and dust mites.
Informed written consent was obtained from each participant. The protocol was approved by the Ethics Committee of the Medical School of the University Erlangen-Nuremberg, Germany.
The data were described by means, standard deviations and proportions.
We used Pearson correlation to investigate the correlation between aluminium concentrations in plasma and urine.
Unpaired t-test were used to find univariate distributional differencies between the cases (occupational disease = yes) and non cases (occupational disease = no) with respect to age (years), weight (kg), height (cm), time of exposure (months), Al -plasma (μg/l), Al -urine (μg/gcreat), FEV1/VC (%), TLC (% pred.), VC (% pred.), Rtot (kPa*s/l) and body mass index. Moreover differencies between cases and non-cases in the distribution of smoking habits was analysed using χ2 test. The next step of the analysis is addressed to the question of the multivariate dependency between several independent factors and the occurrence of an occupational disease (aluminosis). If the univariate p-value of distributional differencies was below 0.40 the corresponding independent factors was included in the multivariate model. The margin p ≤ 0.4 is chosen to be rather conservative, because of the limited sample size. Thus the multivariate associations between the occurrence of an aluminosis and age, sex, smoking habits, lung function parameters (vital capacity, total resistance, forced expiratory volume) and biological monitoring were studied using a logistic regression model. Differences with a p-value smaller or equal to 0.05 were regarded as significant.
Statistical analysis were performed using proc ttest, freq and logist with SAS® software.
Occupational and disease history
The 62 male workers (plant A: 28; plant B: 34) were exposed to aluminium powder for a median of 123 months (range 13 – 360 months) as stampers (n = 11), polishers (n = 7), dryers (n = 6), packers (n = 4), mixers (n = 10), ball mill operators (n = 11) and others as controllers, metalworkers etc. (n = 7). Former exposure to fibrotic agents was reported by 14 workers. 11 were exposed to asbestos as construction workers (n = 3), metalworkers (n = 6) and car mechanics (n = 2), and 3 to silica dusts. Exposure to other fibrotic agents at the current workplace (e.g. other metals including cobalt, beryllium etc.) can be excluded. 15 workers reported a chronic cough and phlegm, 11 of them were smokers. 9 had a positive history of pneumonia, pleuritis or tuberculosis. Four workers reported shortness of breath during exercise.
The median aluminium concentration in plasma was 12.5 μg/l (range 2.5 – 84.4 μg/l) and in urine 83.3 μg/l (range 3.7 – 630.0 μg/l) or 104.3 μg/g creat. (range 7.9 – 821.2 μg/g creat.). The BAT value of 200 μg/l urine was exceeded in 20 cases (32.3 %). The aluminium concentrations in plasma and urine showed a significant correlation (r = 0.83) related to the urinary Al concentration in μg/l and r = 0.93 related to μg/gcreat. (Figure 2).
The intensity of exposure depended on the workplace area. A detailed description of the internal aluminium exposure at the different workplaces is shown in Table 1. The highest aluminium concentrations in biological materials were found in stampers.
Chest X-rays were performed with the first 28 workers investigated. In 3 patients small rounded and irregular opacities with a profusion of 1/0 (n = 2) and 1/2 (n = 1) according to the ILO-classification were found. The findings were described by the radiologist as non-specific.
HRCT revealed in 15 of 62 workers (24.2%) parenchymal changes of the same pattern. This was characterized by small rounded opacities predominantly in the upper lung regions. Moreover there were signs of a beginning thickening of the interlobular septae in three cases. In four cases these opacities were located additionally in the middle and lower lobes. The rounded opacities had a maximum diameter of 3 mm. 9 of the 15 workers with rounded opacities had worked as stampers and were exposed to barely greased or non-greased aluminium-flake powder.
10 of 15 workers with HRCT findings were found to have aluminium concentrations in urine above the threshold limit value of 200 μg/l (Fig. 2).
Workers with aluminium-induced CT-findings
Workers with HRCT changes had worked as stampers (n = 9), polishers (n = 2), ball mill operators (n = 2), mixers (n = 1) and sievers (n = 1). Affected workers had higher concentrations of aluminium in plasma (AI-plasma, p = 0.01) and urine (AI-urine, p = 0.003) and a lower vital capacity (p = 0.01) (table 3). The age, time of exposure, total lung capacity (TLC), resistance (Rtot), and the results of the Tiffeneau-test (FEV1/VC) did not differ between workers with and without lung changes induced by aluminium dust in the univariate comparison between the groups (table 3). Smoking habits, including number of pack-years, had no influence on the prevalence of HRCT changes (χ2 test, p = 0.5028) (table 2). Parenchymal changes did not correlate with the existance of respiratory symptoms. Higher (200 and more) aluminium concentrations in urine (with relation to creatinine) and higher (120 days and more) duration of exposure were significantly associated with aluminosis. Vital capacity and FEV1/VC were factors of borderline significance (table 4). Including aluminium concentration in urine without correction for creatinine and aluminium concentration in plasma into the regression model yielded to similar results. With these variations the model fit was slightly worse.
4 of 15 affected workers (26.7%) and 10 of 42 (23.8%) non-affected workers were exposed to fibrotic agents in former occupations. 5 affected workers reported symptoms of chronic bronchitis, 4 reported shortness of breath induced by exercise. During further medical work-up of the 15 affected workers, exercise induced decrease in pO2 occured in 4 cases (table 5, Nos. 2,10,12,14). 8 patients presented positive results in immunological tests for specific IgE, indicating sensitization to environmental antigens. None of them had any symptoms which suggested a clinical relevance of these findings. Auto-antibodies were slightly positive in three cases (n = 2 ANA, ANA normal value < 1:10; sjoegren syndrome antigen La normal value < 1) without clinical signs of a corresponding disease (table 6). In 11 of 15 cases results from biological monitoring of Al in plasma were available from former years. The Al-concentrations ranged between 9.8 μg/l and 183 μg/l (median 85 μg/l, arithmetic mean 84.6 μg/l) (table 6).
Lung diseases induced by aluminium dust are very rare in occupational medicine. Between 1960 and 1989 only a few individual cases were identified, mainly in the aluminium powder industry. It was assumed that under today's working conditions lung fibrosis induced by aluminium dust was virtually non-existant [6, 7]. In former times, it was even proposed that workers exposed to silica inhale aluminium lactate to suppress the development of silicosis [19, 20]. Since the beginning of the 90s, however, several cases of severe fibrosis have been recognized by the employers'liability insurance and financially compensated in Germany . Young men with only short periods of exposure were also affected and the prognosis was poor . In other aluminium industries the existence of aluminium-induced lung diseases is the subject of much controversy [21, 22]. In most studies, especially in cross-sectional studies of workers exposed to aluminium, no increase in the prevalence of pneumoconiotic changes was found using conventional chest X-rays [9, 23]. In one study, Townsend et al  classified an increase in small irregular opacities in aluminium smelters as non-specific changes. De Vuyst et al  reported severe lung fibrosis in an aluminium polisher. Early stages of aluminosis have not yet been described.
In recent years the use of high resolution computed tomography (HRCT) has proved very reliable for the detection of occupationally induced pneumoconiosis . In several studies HRCT could be shown to have higher sensitivity and specificity compared to conventional chest X-rays, in particular for asbestos-related diseases [26–28]. So far there are only case reports available on the use of HRCT with workers exposed to aluminium dust [10, 29]. They described advanced stages of aluminosis. The predominant CT findings consist of subpleural bullae, and parenchymal changes with distortion of intrathoracal structures. Early stages of aluminosis have not been specified using either conventional X-rays or CT.
In 15 of 62 high exposed workers we were able to detect early stages of aluminosis for the first time using HRCT. The CT findings are specified by small rounded and ill-defined centrilobular opacities mainly in the upper lobes which cannot be assessed using chest X-rays. The CT findings suggest beginning alveolitis, without fibrotic activity. Severe cases from the same plants show that there is a considerable risk of these early stages progressing to severe fibrosis  (Fig. 1). Unfortunately the 15 affected workers in this study refused to undergo bronchoscopy so that no biopsy results are available. Immediate intervention took place to reduce aluminium exposure in both plants. Affected workers were removed from workplaces with high exposures.
Fig 2 shows that not all highly exposed workers were found to have parenchymal changes. This suggests that individual susceptibility plays an important role in the development of aluminosis. Neither the smoking habits nor cumulative cigarette consumption in pack-years differ between affected and non-affected workers (Tables 2 and 3). As stampers and subjects with increased and longer exposure were over-represented in the affected group, type, duration and intensity of exposure seem to be the most important risk factors besides unknown individual ones. Stampers are exposed to a very fine flake powder with a high proportion of flakes with a diameter below 5 μm. Lung function analysis has a low sensitivity for detecting affected workers and is therefore not an appropriate tool for screening exposed workers. Affected workers, however, had a 10 % lower vital capacity than non-affected workers on a group basis (Table 3).
All workers have had regular medical check-ups involving anamnesis, lung function tests and chest X-rays not exhibiting early stages of aluminosis. When interpreting the significant correlations between Al-concentrations in plasma and urine and the presence of aluminosis, it has to be considered that the results of biological monitoring represent acute exposure while the development of aluminosis is likely to be a chronic effect. In 11 of 15 affected workers, results from biological monitoring of Al in plasma were available (table 5b). These show that Al exposure has been, at least during the last 10 years, very high. For diagnostic purposes HRCT proved to be more sensitive and specific than chest X-rays for identifying lung disease induced by aluminium dust. However, it is not possible to use HRCT as a screening tool in an undifferentiated way because of the high costs and considerably higher radiation exposure compared to chest X-rays. For the selective use of HRCT, high-risk groups must be defined on the basis of risk factors . Our study showed that job classification, e.g. working as a stamper for many years and, high aluminium concentrations in plasma and urine are the best markers of workers at risk.
Radiomorphological patterns suggest that aluminosis develops from alveolitis, as has been shown for other pneumoconiotic diseases . Long-term follow-up of the affected workers will show whether and to what extent regression of the disease is possible. Etiologic agents and pathogenetic considerations other than aluminium cannot be supported.
Arguments for aluminium-induced changes are supported by (1) the consistent pattern in all affected workers, (2) the fact that there is a dose-dependency in the findings (3) that the changes were found in two different plants and (4) the lack of results that would support another hypothesis.
The exposure of 3 workers to asbestos and of 1 worker to crystalline silica cannot be responsible for the radiological findings in those cases. The sensitization of 8 affected workers to environmental antigens is without clinical relevance because none of them reported characteristic symptoms. Moreover, type-I sensitization does not lead to alveolitic changes in the lungs. Specific IgG antibodies or symptoms that are typical of hypersensitivity pneumonitis due to environmental antigens could not be found. The three slightly positive antibodies (two ANA, one SS-AG-La) are without clinical relevance because there were no other findings suggesting an auto-immune disease of any kind.
In the scientific literature it has been discussed for many years whether only non-greased aluminium powder or special additives such as stearic acid are responsible for the development of fibrosis induced by aluminium dust [4, 5, 8]. In our group all participants were exposed to a mixture of non-greased and at least barely greased aluminium powder. Parenchymal changes induced by aluminium dust were present mainly in workers that were exposed to barely or non-greased aluminium powder at the stamping workplaces. The highest exposures to aluminium dust exist at these workplaces and most of this aluminium dust is respirable with a diameter smaller than 5 μm. Lung changes induced by aluminium dust in workers that were exposed to only greased aluminium powder could not be detected in our study. Barely greased or non-greased aluminium powder is therefore thought to be the main pathogenetic risk factor for the development of lung fibrosis induced by aluminium dust, although it is still not clear whether greased aluminium powder alone can cause aluminium-induced lung diseases.
Aluminium is of growing importance in industry and adequate substitutes will not be available in the near future. Our findings show that aluminosis is still relevant in occupational medicine. Probably the detection of early stages of aluminosis is not due to a recurrence of a historical disease but to the use of more sensitive diagnostic tools. However, it is important that in addition to a reduction in exposure also specific and efficient measures of secondary prevention are implemented. Biological monitoring is the most easily available and suitable tool for the identification and screening of high risk groups . Our findings also show that in high-risk groups, HRCT can be an important complementary tool for the early detection of aluminosis.
Sjögren B, Iregren A, Frech W, et al.: Effects on the nervous system among welders exposed to aluminium and manganese. Occ Environ Med 1996, 53: 32–40.
Strong MJ, Garruto RM, Joshi JG, et al.: Can the mechanisms of Aluminium neurotoxicity be integrated into a unified scheme? J Toxicol Environ Health 1996, 48: 599–613. 10.1080/009841096161096
Savory J, Exley C, Forbes WF, et al.: Can the controversy of the role of aluminium in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? J Toxicol Environ Hlth 1996, 48: 615–635. 10.1080/009841096161104
Dinman D: Aluminium in the Lung: The Pyropowder Conundrum. J Occup Med 1987, 29: 869–876.
Koelsch F: Das Aluminium in der Arbeits- und Versicherungsmedizin. Darmstadt, Dr. Dietrich Steinkopff Verlag; 1964.
Morgan W, Dinman B: Pulmonary effects of aluminum. In Aluminum and health. Edited by: Gitelman HJ. New York, Basel, Marcel Dekker, Inc; 1989:209–234.
Reichel G: Aluminiumstaubpneumokoniose. In Pneumokoniosen. Edited by: Ulmer WT, Reichel G. Berlin, Heidelberg, New York, Springer Verlag; 1976:484–487.
Hartung M, Manke HG, Schmid K, Letzel S: Lungenfibrosen durch Aluminiumpulver. In Verh Dtsch Ges Arbeitsmed Umweltmed. Edited by: Schuckmann F, Schopper-Jochum S. Stuttgart, Gentner Verlag; 1990:263–268.
Letzel S: Arbeitsmedizinische Untersuchungen zur Belastung und Beanspruchung in der aluminiumpulverherstellenden Industrie. In Sonderschrift 8. Edited by: Schriftenreihe der Bundesanstalt für Arbeitsmedizin. Berlin, Bremerhaven, Wirtschaftsverlag NW, Verlag für neue Wissenschaft GmbH; 1994.
Dehm B, Letzel S, Raithel HJ, et al.: Lungenfibrose nach beruflicher Aluminiumstaubexposition. Arbeitsmed Sozialmed Umweltmed 1996, 31: 161–164.
Deutsche Forschungsgemeinschaft: List of MAK and BAT Values. In Report No. 35. Edited by: Greim H. Weinheim, Wiley-VCH; 2000.
Kraus T, Raithel HJ, Hering KG: Evaluation and Classification of high resolution computed tomography findings in patients with pneumoconiosis. Int Arch Occ Environ Health 1996, 68: 249–254.
Schaller KH, Letzel S, Angerer J: Aluminium. In Handbook on Metals in Clinical Chemistry. Edited by: Seiler H, Sigel A, Sigel H. New York, Basel, Marcel Dekker; 1994:217–226.
Lehnert G, Schaller KH, Angerer J: Report on the status of the external quality-control programs for occupational-medical and environmental-medical toxicological analyses in biological materials in Germany. Int Arch Occup Environ Health 1999, 72: 60–64. 10.1007/s004200050336
American Thoracic Society: Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995, 152: 1107–1136.
Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced expiratory flows. Eur Respir J 1993, 6: 5–40.
International Labour Office: International classification of radiographs of pneumoconiosis. Occupational safety and health series. No. 22 (rev 80). Geneva, International Labour Office; 1980.
Kraus T, Schaller KH, Angerer J, Letzel S: Aluminium dust-induced lung disease in the pyro-powder-producing industry: detection by high-resolution computed tomography. Int Arch Occup Environ Health 2000, 73: 61–64. 10.1007/PL00007939
Dubois F, Begin R, Cantin A, et al.: Aluminium inhalation reduces silicosis in a sheep model. Am Rev Respir Dis 1988, 137: 1172–1179.
Begin R, Masse S, Rola-Pleszczynski M, et al.: Aluminum lactate treatment alters the lungs biological activity of quartz. Exp Lung Research 1986, 10: 385–399.
Abramson MJ, Wlodarczyk JH, Saunders NA, Hensley MJ: Does aluminum smelting cause lung disease? Am Rev Respir Dis 1989, 139: 1042–1057.
Jederlinic PJ, Abraham JL, Churg A, Himmelstein JS, Epler GR, Gaensler EA: Pulmonary fibrosis in aluminum oxide workers – Investigation of nine workers with pathologic examination and microanalysis in three of them. Am Rev Respir Dis 1990, 142: 1179–1184.
Saia B, Cortese S, Piazza G, et al.: Chest x-ray findings among aluminium production plant workers. Med Lavoro 1981, 4: 323–329.
Townsend MC, Sussman NB, Enterline PE, et al.: Radiographic abnormalities in relation to total dust exposure at a bauxite refinery and alumina-based chemical products plant. Am Rev Respir Dis 1988, 138: 90–95.
DeVuyst P, Dumortier P, Rickaert F, VanDeWeyer R, Lenglud C, Yernault JC: Occupational lung fibrosis in an aluminium polisher. Eur J Respir Dis 1986, 68: 131–140.
Kraus T, Raithel HJ: Frühdiagnostik Asbest-verursachter Erkrankungen. Schriftenreihe des Hauptverbands der gewerblichen Berufsgenossenschaften. DCM, Druck Center Meckelheim; 1998.
Friedman AC, Fiel SB, Fisher MS, et al.: Asbestos-related pleural disease and asbestosis: a comparison of CT and chest radiography. AJR 1988, 150: 269–275.
Aberle DR, Gamsu R, Ray CS, Feuerstein IM: Asbestos-related pleural and parenchymal fibrosis: Detection with High-Resolution CT. Radiology 1988, 166: 729–734.
Akira M: Uncommon Pneumoconioses: CT and Pathologic Findings. Radiology 1995, 197: 403–409.
Letzel S, Schaller KH, Angerer J, et al.: Biological Monitoring of occupational Aluminium Powder Exposure. Occ Hyg 1996, 3: 271–280.
Akira M, Yokoyama K, Yamamoto S, et al.: Early asbestosis: evaluation with high-resolution CT. Radiology 1991, 178: 409–416.
The study was supported by a grant from the Koelsch-Stiftung e.V.
We thank the occupational health physicians and the technical staff from the participating companies. Special thanks to Kathy Bischof for her editorial assistance.